Vita Coco Company, Inc. 10-K

Item 8. Financial Statements and Supplementary Data. The financial statements required to be filed pursuant to this Item 8 are appended to this report. An index of those financial statements is set forth below: I NDEX TO C ONSOLIDATED F INANCIAL S TATEMENTS Audited Consolidated Financial Statements Page Reports of Independent Registered Public Accounting Firm (PCAOB ID No. 34 ) 58 Consolidated Balance Sheets as of December 31, 2025 and 2024 61 Consolidated Statements of Operations & Other Comprehensive Income (Loss) for the years ended December 31, 2025, 2024 and 2023 62 Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2025, 2024 and 2023 63 Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024 and 2023 64 Notes to Consolidated Financial Statements 65 57 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the stockholders and the Board of Directors of The Vita Coco Company, Inc. New York, New York Opinion on Internal Control over Financial Reporting We have audited the internal control over financial reporting of The Vita Coco Company, Inc. and subsidiaries (the “Company”) as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2025, of the Company and our report dated February 18, 2026, expressed an unqualified opinion on those financial statements. Basis for Opinion The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. Definition and Limitations of Internal Control over Financial Reporting A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. /s/ Deloitte & Touche LLP New York, New York February 18, 2026 58 Table of Contents REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the stockholders and the Board of Directors of The Vita Coco Company, Inc.: Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of The Vita Coco Company, Inc. and subsidiaries (the "Company") as of December 31, 2025 and 2024, the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows, for each of the three years in the period ended December 31, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 18, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting. Basis for Opinion These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. Critical Audit Matter The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. Trade Promotion Accruals — Refer to Note 2 to the financial statements Critical Audit Matter Description The Company’s contracts with customers include variable consideration, including trade promotions. Variable consideration is treated as a reduction in revenue when the related revenue is recognized, and is recorded using the expected value method, with updates to estimates and related accruals of variable consideration occurring each period based on historical experience and changes in circumstances. We identified the estimation of trade promotion accruals by management as a critical audit matter. These accruals are based on contract terms and the Company’s historical experience with similar programs and requires management judgment with respect to estimating customer and consumer participation and performance results. Consequently, auditing these assumptions require subjective auditor judgment. How the Critical Audit Matter Was Addressed in the Audit Our audit procedures related to trade promotion accruals included the following, among others: 59 Table of Contents • We tested the effectiveness of management’s controls over the estimation and calculation of the trade promotion accruals, including management’s controls over the review of the period-end accrual. • We selected a sample of individual customers included in management’s detail of the recorded trade promotion accruals, and evaluated inputs relevant to recorded amounts, including contractual pricing and rebate arrangements with customers, which were compared to source documents. • We selected a sample of subsequent payments, inspected relevant source documents, determined if they pertained to trade promotions that should have been recorded as of year-end, and compared to recorded amounts. /s/ Deloitte & Touche LLP New York, New York February 18, 2026 We have served as the Company’s auditor since 2012. 60 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2025 AND 2024 (Amounts in thousands, except share data) December 31, 2025 2024 Assets Current assets: Cash and cash equivalents $ 196,873 $ 164,669 Accounts receivable, net of allowance of $ 2,660 at December 31, 2025, and $ 2,255 at December 31, 2024 81,514 63,450 Inventory 111,468 83,600 Supplier advances, current 693 954 Derivative assets 732 1,382 Prepaid expenses and other current assets 30,160 27,236 Total current assets 421,440 341,291 Property and equipment, net 9,298 2,351 Goodwill 7,791 7,791 Supplier advances, long-term 1,860 2,254 Deferred tax assets, net 6,463 6,100 Right-of-use assets, net 11,592 385 Other assets 2,714 2,209 Total assets $ 461,158 $ 362,381 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 25,464 $ 30,758 Accrued expenses and other current liabilities 89,458 65,603 Notes payable, current 3 10 Derivative liabilities 1,507 6,895 Total current liabilities 116,432 103,266 Notes payable, long-term — 3 Operating lease liability, long-term 13,087 — Other long-term liabilities 97 295 Total liabilities $ 129,616 $ 103,564 Contingencies (See Note 11) Stockholders’ equity: Common stock, $ 0.01 par value; 500,000,000 shares authorized; 64,186,549 and 63,702,387 shares issued at December 31, 2025 and December 31, 2024, respectively; 57,082,173 and 56,961,941 shares outstanding at December 31, 2025 and December 31, 2024, respectively. 642 637 Additional paid-in capital 185,400 174,077 Retained earnings 228,014 156,694 Accumulated other comprehensive gain (loss) 486 ( 860 ) Treasury stock, 7,104,376 shares at cost as of December 31, 2025, and 6,740,446 as of December 31, 2024. ( 83,000 ) ( 71,731 ) Total stockholders’ equity $ 331,542 $ 258,817 Total liabilities and stockholders’ equity $ 461,158 $ 362,381 See accompanying notes to the consolidated financial statements. 61 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS & OTHER COMPREHENSIVE INCOME (LOSS) FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Year Ended December 31, 2025 2024 2023 Net sales $ 609,780 $ 516,013 $ 493,612 Cost of goods sold 387,185 317,230 312,883 Gross profit 222,595 198,783 180,729 Operating expenses Selling, general and administrative 140,063 124,963 124,236 Total operating expenses 140,063 124,963 124,236 Income from operations 82,532 73,820 56,493 Other income (expense) Unrealized gain/(loss) on derivative instruments 4,737 ( 8,176 ) ( 872 ) Foreign currency loss ( 1,037 ) ( 1,571 ) ( 251 ) Interest income, net 6,548 6,715 2,550 Other income 191 — — Total other income (expense) 10,439 ( 3,032 ) 1,427 Income before income taxes 92,971 70,788 57,920 Income tax expense 21,651 14,836 11,291 Net income $ 71,320 $ 55,952 $ 46,629 Other comprehensive income (loss) Foreign currency translation adjustment $ 1,346 $ ( 211 ) $ 345 Total comprehensive income attributable to The Vita Coco Company, Inc. $ 72,666 $ 55,741 $ 46,974 Net income attributable to The Vita Coco Company, Inc. per common share Basic $ 1.25 $ 0.99 $ 0.83 Diluted $ 1.19 $ 0.94 $ 0.79 Weighted-average number of common shares outstanding Basic 56,913,810 56,729,370 56,427,890 Diluted 59,967,691 59,286,562 58,747,338 See accompanying notes to the consolidated financial statements. 62 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except share amounts) Common Stock Common Stock with Exit Warrants Total Common Stock Additional Paid-In Capital Retained Earnings (Accumulated Deficit) Accumulated Other Comprehensive Income / (Loss) Treasury Stock Total Stockholders' Equity Shares $Amount Shares $Amount Shares $Amount Shares $Amount Balance at December 31, 2022 54,112,145 541 8,113,105 81 62,225,250 622 145,210 55,183 ( 994 ) 6,206,200 ( 58,928 ) 141,093 Net income — — — — — — — 46,629 — — — 46,629 Cumulative-effect adjustment related to the adoption of accounting guidance for credit losses — — — — — — — ( 1,070 ) — — — ( 1,070 ) Purchase of treasury stock — — — — — — — — — 30,000 ( 773 ) ( 773 ) Stock-based compensation — — — — — — 9,128 — — — — 9,128 Exercise of stock awards 910,203 9 — — 910,203 9 7,076 — — — — 7,085 Foreign currency translation adjustment — — — — — — — — 345 — — 345 Balance at December 31, 2023 55,022,348 $ 550 8,113,105 $ 81 63,135,453 $ 631 $ 161,414 $ 100,742 $ ( 649 ) 6,236,200 $ ( 59,701 ) $ 202,437 Net income — — — — — — — 55,952 — — — 55,952 Purchase of treasury stock — — — — — — — — — 504,246 ( 12,030 ) ( 12,030 ) Stock-based compensation — — — — — — 8,922 — — — — 8,922 Exercise of stock awards 566,934 6 — — 566,934 6 3,741 — — — — 3,747 Foreign currency translation adjustment — — — — — — — — ( 211 ) — — ( 211 ) Balance at December 31, 2024 55,589,282 $ 556 8,113,105 $ 81 63,702,387 $ 637 $ 174,077 $ 156,694 $ ( 860 ) 6,740,446 $ ( 71,731 ) $ 258,817 Net income — — — — — — — 71,320 — — — 71,320 Purchase of treasury stock — — — — — — — — — 363,930 ( 11,269 ) ( 11,269 ) Stock-based compensation — — — — — — 10,843 — — — — 10,843 Exercise of stock awards 484,162 5 — — 484,162 5 480 — — — — 485 Foreign currency translation adjustment — — — — — — — — 1,346 — — 1,346 Balance at December 31, 2025 56,073,444 $ 561 8,113,105 $ 81 64,186,549 $ 642 $ 185,400 $ 228,014 $ 486 7,104,376 $ ( 83,000 ) $ 331,542 See accompanying notes to the consolidated financial statements. 63 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands) Year Ended December 31, 2025 2024 2023 Cash flows from operating activities: Net income $ 71,320 $ 55,952 $ 46,629 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 1,072 745 660 Amortization of debt issuance costs 16 — — Loss on disposal of equipment 1 13 19 Provision for credit losses 2,023 1,603 260 Unrealized (gain)/loss on derivative instruments ( 4,737 ) 8,176 872 Stock-based compensation 10,843 8,922 9,128 Impairment loss on assets held for sale — — 363 Impairment loss on Runa assets 185 — — Noncash lease expense 1,356 1,021 1,288 Deferred tax expense ( 366 ) 644 ( 2,382 ) Changes in operating assets and liabilities: Accounts receivable ( 18,568 ) ( 14,171 ) ( 7,088 ) Inventory ( 27,324 ) ( 32,984 ) 33,688 Prepaid expenses, net supplier advances, and other assets 130 ( 2,691 ) ( 622 ) Accounts payable, accrued expenses, and other liabilities 11,223 15,669 24,340 Net cash provided by operating activities 47,174 42,899 107,155 Cash flows from investing activities: Cash paid for property and equipment ( 8,149 ) ( 974 ) ( 599 ) Proceeds from sale of property and equipment — — 5 Equity method investment in joint venture ( 104 ) — — Net cash used in investing activities ( 8,253 ) ( 974 ) ( 594 ) Cash flows from financing activities: Proceeds from exercise of stock awards 3,745 3,747 7,086 Cash paid on notes payable ( 10 ) ( 13 ) ( 23 ) Cash paid to acquire treasury stock ( 11,269 ) ( 12,030 ) ( 773 ) Net cash provided by (used in) financing activities ( 7,534 ) ( 8,296 ) 6,290 Effects of exchange rate changes on cash and cash equivalents 834 ( 563 ) 387 Net increase in cash and cash equivalents 32,221 33,066 113,238 Cash, cash equivalents and restricted cash at beginning of the period 165,933 132,867 19,629 Cash, cash equivalents and restricted cash at end of the period (1) $ 198,154 165,933 132,867 Supplemental disclosures of cash flow information: Cash paid for interest $ — 1 75 (1) Includes $ 1,281 , $ 1,264 and $ 330 of restricted cash as of December 31, 2025 , 2024, and 2023 respectively, that were included in other current assets. See accompanying notes to the consolidated financial statements. 64 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) 1. NATURE OF BUSINESS AND BASIS OF PRESENTATION The Vita Coco Company, Inc. and subsidiaries (the “Company”) develops, markets, and distributes various coconut water products under the brand name Vita Coco and for retailers' own brands ("Private Label"), predominantly in the United States ("U.S."). Other products include coconut milk, coconut oil, and protein infused fitness drinks (under the brand name PWR LIFT) . The Company was incorporated in Delaware as All Market Inc. on January 17, 2007. On September 9, 2021, the Company changed its name to The Vita Coco Company, Inc. In 2018, the Company purchased certain assets and liabilities of Runa , which was marketed and distributed primarily in the U.S. until the Company ceased selling the brand in December 2023 and impaired all remaining assets in September 2025. The Company completed an initial public offering (the "IPO") of common stock in October 2021. The Company is a public benefit corporation under Section 362 of the Delaware General Corporation Law. As a public benefit corporation, the Company's Board is required by the Delaware General Corporation Law to manage or direct its business and affairs in a manner that balances the pecuniary interests of its stockholders, the best interests of those materially affected by its conduct and the specific public benefits identified in its certificate of incorporation. The Company has ten wholly-owned subsidiaries including four wholly-owned Asian subsidiaries established between fiscal 2012 and 2015, four North American subsidiaries established between 2012 and 2018, as well as All Market Europe, Ltd. (“AME”) in the United Kingdom ("U.K.") established during 2009, and one subsidiary in Germany established during 2024. Through one of its subsidiaries, the Company has a 60 % joint venture interest in a company, Coco Ventures Limited, which provides for the development, marketing, distribution and branding of coconut water-based products under the Vita Coco brand in China. See Note 22, Joint Venture, for further details. Basis of Presentation The accompanying consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Certain reclassifications have been made to previously reported consolidated financial statements to conform to the presentation as of and for the year ended December 31, 2025. Principles of Consolidation The consolidated financial statements include all the accounts of the wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Impact of Global Events Causing Macroeconomic Uncertainty Uncertainty in the macroeconomic environment resulting from current geopolitical and economic instability (including the effects of current wars and other international conflicts) and the high interest rates, foreign exchange rates, tariffs, and other import related fees, and inflationary cost environment may affect the Company's global supply chain. It is not currently possible to ascertain the overall impact of these macroeconomic uncertainties on the Company’s business, results of operations, financial condition or liquidity. Future events and effects related to these macroeconomic uncertainties cannot be determined with precision and actual results could significantly differ from estimates or forecasts. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates Preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in 65 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the consolidated financial statements relate to the determination of the value of trade promotions, share-based compensation, estimating the net realizable value of inventories, the determination of the current expected credit losses, assessing the realizability of deferred income taxes, assessing long-lived assets for impairment, and assessing goodwill for impairment. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue in accordance with ASC 606. ASC 606 defines a five-step model that requires entities exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying the performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. Revenue is recognized when control of the promised good is transferred to the customer in an amount that reflects the consideration to which the Company is expected to be entitled to receive in exchange for those products. Each contract includes a single performance obligation to transfer control of the product to the customer. The Company's revenue is recognized net of allowances for returns, discounts, credits and any taxes collected from consumers. For the Company’s various products in the Vita Coco Coconut Water and Other product categories (refer to Note 3, Revenue Recognition ), control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. The transaction price recognized reflects the consideration the Company expects to receive in exchange for the sale of the product. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that would meet the criteria for a distinct good or service that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent fulfillment costs, which are included in cost of goods sold, rather than revenue. Additionally, the Company determined the production and distribution of Private Label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these Private Label products over time as the production for open purchase orders is completed, which may be prior to any shipment. The resulting contract assets are recorded in prepaid expenses and other current assets. The Company provides trade promotions and sales discounts to its customers and distributors. Since these sales promotions and sales discounts do not meet the criteria for a distinct good or service, they are primarily accounted for as a reduction of revenue and include payments to customers and distributors for performing activities on its behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. These consolidated financial statements include accruals for these promotions and discounts. The accruals are made for invoices that have not yet been received as of year-end and are recorded as a reduction of sales, and are based on contract terms and the Company's historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Cost of Goods Sold Costs of goods sold includes the costs of the products sold to customers, inbound and outbound shipping and handling costs, freight and duties, shipping and packaging supplies, and warehouse fulfillment costs incurred in operating and staffing warehouses. Shipping and Handling Costs 66 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Shipping and handling costs related to the sale of inventory represent outbound distribution costs, and are included in cost of goods sold in the consolidated statement of operations. Shipping and handling costs were $ 17,424 , $ 13,100 and $ 13,261 for the years ended December 31, 2025, 2024, and 2023, respectively. Marketing and Promotional Expenses Marketing and promotional expenses, including advertising expenses, consist of investments to grow our business and retain customers, including costs related to influencers, trade shows, product samples, advertising campaigns on social media and various other digital platforms, point of sale displays, and various event sponsorships. Marketing and promotional expenses are recorded in selling, general and administrative expenses in the period they are incurred and were $ 35,264 , $ 31,343 , and $ 35,460 for the years ended December 31, 2025, 2024, and 2023, respectively. Research and Development Research and development costs are charged to expense in the period incurred and are recorded in selling, general and administrative expenses. Research and development expenses were $ 399 , $ 398 , and $ 418 for the years ended December 31, 2025, 2024, and 2023, respectively. Leases The Company leases certain office space and machinery and equipment, which are classified as operating leases. These leases expire at various dates through 2034. The Company's lease agreements do not contain any material restrictive covenants. Right of use ("ROU") assets and corresponding lease liabilities are recognized at the commencement date based on the present value of future lease payments over the expected lease term and are included within ROU assets, net, in accrued expenses, and other long-term liabilities in its Consolidated Balance Sheets. Lease terms include options to extend or terminate the lease when it is reasonably certain that such options will be exercised. Operating lease expense is recognized on a straight‑line basis over the lease term. The Company does not have any finance leases. The Company has also elected the short‑term lease exemption and therefore does not recognize ROU assets or lease liabilities for leases with terms of 12 months or less. Payments for short‑term leases are recognized as expense on a straight‑line basis over the lease term. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC 718 for awards issued under the 2014 Stock Option and Restricted Stock Plan and the 2021 Stock Incentive Award Plan. The Company measures all awards based on their fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period of each stock award grant, which is generally the vesting period of the respective award by using the accelerated attribution method. The Company applies an estimated forfeiture rate derived from historical employee termination behavior. If the actual forfeitures differ from those estimated by management, adjustment to compensation expense may be required in future periods. Stock awards are equity-classified, as they do not contain a cash settlement option or other features requiring them to be liability-classified. The Company issues stock-based awards with service-based and performance-based and market-based vesting conditions. The Company recognizes expense for performance-based awards when it becomes probable that such awards will be earned over a requisite service period. The actual number of shares ultimately earned may range from zero up to a contractual maximum and may exceed the target number of shares granted if performance results exceed the applicable performance targets . Compensation expense for performance‑based awards is recognized over the requisite service period based on the Company’s assessment of whether the performance conditions are probable of achievement and the estimated number of shares expected to vest. The Company uses the Black-Scholes option-pricing model to determine the fair value of stock awards with service-based vesting conditions and performance-based vesting conditions. For stock awards with performance-based and market-based vesting conditions, the Company uses the Barrier option valuation model to determine the fair value. 67 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) The Company has classified most of its stock-based compensation expense in its consolidated statements of operations in selling, general, and administrative expenses, reflecting the same manner in which the award recipient’s payroll costs are classified or in which the award recipient’s service payments are classified. There are restricted stock units ("RSUs") previously granted to entities affiliated with a major customer, which was recognized as a stock-based sales incentive based on guidance in ASC 606 and reflected as a reduction in the transaction price revenue. See Note 14, Stockholders' Equity for further information. Income Taxes The Company accounts for income taxes under ASC Topic 740, Income Taxes ("ASC 740"), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for differences between the consolidated financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future. Such deferred income tax assets and liabilities computations are based on enacted tax laws and rates applicable to periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred income tax assets to the amount that is more likely than not to be realized. Interest and penalties related to unrecognized tax positions are included in income tax expense in the consolidated statement of operations and comprehensive income and accrued expenses in the consolidated balance sheets. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Net Income per Common Share In accordance with ASC Topic 260 Earnings Per Share ("ASC 260"), net income per common share, on a basic and diluted basis, is presented for all periods, calculated using the treasury stock method. Basic net income per share is computed by dividing net income by the weighted average number of common shares and service warrants outstanding during each period. Diluted net income per share is computed by dividing net income by the weighted average number of common and dilutive common equivalent shares outstanding. The calculation of common equivalent shares assumes the exercise of dilutive in-the-money stock options, net of assumed treasury share repurchases at average market prices, as applicable. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and money market instruments with maturities of three months or less. Accounts Receivable Accounts receivable are reported net of an allowance for credit losses. In determining such an allowance, the Company considers historical losses and existing economic conditions, as well as the credit quality of each customer. Accounts receivable are charged off when the Company deems amounts to be uncollectible. Inventory Inventory represents raw materials, finished goods, packaging, and inbound shipping and handling and is reported at the lower of cost or net realizable value being determined using the first-in, first-out method. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reserves for finished goods that are close to the date of expiration. Property and Equipment Property and equipment are stated at cost and are depreciated over the estimated useful lives of the related assets or in the case of leasehold improvements, the lease term if shorter, using the straight-line method of depreciation. Repairs and maintenance are charged to expense as incurred. The estimated useful lives of the Company’s property and equipment are as follows: 68 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) • Equipment and computer software and hardware – 3 - 7 years • Leasehold improvements – The lesser of the life of the asset or the term of the lease • Vehicles – 5 years • Furniture and fixtures – 3 - 5 years Intangible assets Intangible assets consisted primarily of acquired trade names and distributor relationships. The Company determines the appropriate useful life of the intangible assets by performing an analysis of expected cash flows of the acquired assets. Intangible assets are amortized over their estimated useful lives of ten years , using the straight-line method, which approximates the pattern in which the economic benefits are consumed. Impairment of Long-Lived Assets The Company evaluates the recoverability of its long-lived assets, principally intangibles and property and equipment, by comparing asset group’s carrying value to the expected undiscounted future cash flows to be generated from such assets when events or circumstances indicate that an impairment may have occurred. If the estimated undiscounted future cash flows are less than the carrying amount, an impairment loss is recorded based upon the difference between the carrying amount and the fair value of the asset. The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable, or a triggering event. When a triggering event is identified, a test of recoverability is performed by estimating the undiscounted future cash flows associated with such assets and comparing them to the carrying value of the asset. When the recoverability test fails, the Company measures the impairment loss based on the fair value of the assets compared to the carrying amount of the asset. The fair value of the trade names is determined through an income approach using the relief from royalty method. The fair value of the distributor relationships is determined through an income approach using the excess earnings method. Goodwill Goodwill represents the purchase price paid in excess of the fair value of net identifiable tangible and intangible assets acquired in a business combination and is measured in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other ("ASC 350"). Goodwill is not amortized; instead goodwill is tested for impairment on an annual basis on December 31, or more frequently if the Company believes indicators of impairment exist. The Company has determined that there are three reporting units for purposes of testing goodwill for impairment: (i) the Americas reporting unit, (ii) the Europe reporting unit, and (iii) the Asia reporting unit. All of the Company’s goodwill is allocated to the Americas reporting unit. The Company first assesses qualitative factors to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. In performing the qualitative assessment, the Company reviews factors both specific to the reporting units and to the Company as a whole, such as financial performance, macroeconomic conditions, industry and market considerations, and the fair value of each reporting unit at the last valuation date. If the Company elects this option and believes, as a result of the qualitative assessment, that it is more likely than not that the carrying value of each of the reporting units exceeds their fair value, the quantitative impairment test is required; otherwise, no further testing is required. Alternatively, the Company may elect to bypass the qualitative assessment and perform the quantitative impairment test instead, or if the Company reasonably determines that it is more-likely-than-not that the fair value is less than the carrying value, the Company performs its annual, or interim, goodwill impairment test by comparing the fair value of each of the reporting units with their carrying amount. The fair value of each of the reporting units is estimated by blending the results from the income approach and the market multiples approach. These valuation approaches consider a number of factors that include, but are not limited to, expected future cash flows, growth rates, discount rates, and comparable multiples from publicly-traded companies in the Company’s industry, and require to make certain assumptions and estimates regarding industry economic factors and future profitability of the Company’s business. It is the Company’s policy to conduct impairment testing based on its most current business plans, projected future revenues and cash flows, which reflect changes anticipated in the economy and the industry. The cash flows are based on five-year financial forecasts developed internally by management and are discounted to a present value using discount rates that properly 69 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) account for the risk and nature of the respective reporting unit’s cash flows and the rates of return market participants would require to invest their capital in the Company’s reporting unit. The Company will recognize an impairment for the amount by which the carrying amount exceeds a reporting unit’s fair value. For the years ended December 31, 2025, 2024, and 2023, there were no impairments recorded. Supplier Advances The Company issues advances to certain manufacturers with interest at rates between 5 % and 7 % with terms extending to February 2028 . These advances are assessed for collectability and an allowance for credit losses is recognized when it is probable that the Company will be unable to collect all amounts due according to the contractual terms. The Company recorded an allowance of $ 1,007 and $ 1,557 as of December 31, 2025 and December 31, 2024, respectively. Foreign Currency The Company’s reporting currency is the U.S. dollar. The Company maintains the financial statements of each entity within the group in its local currency, which is also the entity’s functional currency. Gains and losses on transactions denominated in currencies other than the functional currency are included in determining net income for the period. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are translated at the average exchange rate applicable during the period. Translation gains and losses are included as a component of accumulated other comprehensive income in stockholders’ equity. Transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included as a component of other income (expense) in the accompanying consolidated statements of operations when incurred. Derivative Instruments The Company periodically enters into forward foreign currency exchange contracts to hedge its foreign currency exposure. The fair value of these contracts is recorded in the consolidated balance sheets with a corresponding adjustment to the consolidated statements of operations for the change in fair value of the derivative instruments, as the contracts have not been designated as a hedge instrument. Refer to Note 12, Derivative Instruments, for more information. Segment Information The Company operates as two operating and reportable segments: (i) Americas segment, which is comprised of the Company’s operations in the Americas region, primarily in the U.S. and Canada, and (ii) International segment, which is comprised of the Company’s operations primarily in Europe, Middle East, Africa and the Asia Pacific regions. Concentration of Credit Risk The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation ("FDIC") up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions and any excess cash above a certain minimum balance could be invested in overnight money market treasury deposits in widely diversified accounts. Substantially, all of the Company’s customers are either wholesalers or retailers of beverages. A material default in payment, a material reduction in purchase from these or any large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company’s financial condition, results of operations, and liquidity. The Company is exposed to concentration of credit risk from its major customers for which two customers represented 44 %, 48 %, and 53 % of total net sales during the years ended December 31, 2025, 2024, and 2023, respectively. In addition, the two customers also accounted for 39 % and 30 % of total accounts receivable as of December 31, 2025 and 2024, respectively. The Company has not experienced credit issues with these customers. Recently Adopted Accounting Pronouncements 70 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Income Taxes In December 2023, the FASB issued ASU 2023-09 , Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities to provide disclosure of specific categories in the rate reconciliation, detail out reconciling items that are equal to or greater than 5% of income from continuing operations before income tax expense multiplied by the applicable statutory income tax rate, and break out income taxes by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance on a retrospective basis for the year ended December 31, 2025. The adoption did not have a material effect on its consolidated financial statements. Segment Reporting In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 was effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the standard for the year ended December 31, 2024. The adoption of the standard did not have a material impact on the Company’s consolidated statements of operations and disclosures. Current Expected Credit Losses In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The new accounting standard introduced the current expected credit losses methodology ("CECL") for estimating allowances for credit losses. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized costs, including loans and trade receivables. ASU 2016-13 was effective for the Company, as an EGC, for annual and interim reporting periods beginning after December 15, 2022. The Company adopted the standard on January 1, 2023 using the modified retrospective method for all financial assets in scope. As a part of the adoption, the Company selected to apply roll-rate method to estimate current expected credit losses for its accounts receivable population and weighted average remaining maturity ("WARM") method for supplier advances. The difference of $ 1,070 between the incurred credit loss estimate and current expected credit loss estimate was recorded as cumulative effect adjustment to the Company’s opening retained earnings and reflected on the consolidated balance sheet as of January 1, 2023 as a result of the ASC 326 adoption. The adoption of the standard did not have a material impact on the Company’s consolidated statements of operations, or consolidated statements of cash flows. The following table illustrates the impact of ASC 326 . As of January 1, 2023 As reported under ASC 326 Pre-ASC 326 adoption Impact of ASC 326 adoption Allowance for credit losses on accounts receivables $ 3,552 $ 2,898 $ 654 Allowance for credit losses on supplier advances 416 — 416 Total $ 3,968 $ 2,898 $ 1,070 Recently Issued Accounting Pronouncements In December 2025, the FASB issued ASU 2025‑11, Interim Reporting (Topic 270): Narrow‑Scope Improvements. The amendments clarify the applicability, content, and disclosure requirements for interim financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP). The objective of ASU 2025‑11 is to improve the clarity and navigability of Topic 270 by consolidating existing interim reporting guidance, specifying required disclosures, 71 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) and establishing a principle that entities disclose events and changes occurring after the most recent annual reporting period that have a material impact on the entity. ASU 2025‑11 is effective for interim periods within annual periods beginning after December 15, 2027, with early adoption permitted. The Company is evaluating the impact on the Company’s interim reporting and disclosures. In September 2025, the FASB issued ASU 2025‑06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software ("ASU 2025-06"). ASU 2025-06 removes the existing project stage model and introduces new capitalization criteria based on management authorization and the probability of project completion. It also clarifies the treatment of software development uncertainty and incorporates guidance on website development costs. ASU 2025-06 is effective for annual periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of ASU 2025-06 on its consolidated financial statements. In July 2025, the FASB issued ASU 2025‑05, Financial Instruments—Credit Losses (“Topic 326”): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”). ASU 2025-05 introduces a practical expedient that allows entities to estimate expected credit losses for current trade receivables and contract assets (within the scope of ASC 606) based on the assumption that current economic conditions will persist over the asset’s remaining life. The expedient applies only to receivables and contract assets that are expected to be collected within one year (or the operating cycle, if longer) and is intended to reduce complexity in applying the credit loss model under Topic 326. The standard is effective for the Company for fiscal years beginning after December 15, 2025, including interim periods within those fiscal years. Early adoption is permitted. The amendments must be applied prospectively. The Company is currently evaluating the impact of ASU 2025-05 on its consolidated financial statements and related disclosures. In November 2024, the FASB issued ASU 2024-03 , Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires expenses in the consolidated statement of operations to be disaggregated into functional categories and separate significant individual expense items that are material to the understanding of the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026. The Company is currently evaluating the impact of adopting ASU 2024-03 . 3. REVENUE RECOGNITION Revenues are accounted for in accordance with ASC 606. The Company disaggregates revenue into the following product categories: • Vita Coco Coconut Water – This product category consists of all branded coconut water product offerings under the Vita Coco labels, where the majority ingredient is coconut water. The Company determined that the sale of the products represents a distinct performance obligation as customers can benefit from purchasing the products on their own or together with other resources that are readily available to the customers. For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. • Private Label – This product category consists of all Private Label product offerings, which includes coconut water and coconut oil. The Company determined the production and distribution of Private Label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these Private Label products over time as the production for open purchase orders occurs, which may be prior to any shipment. • Other – This product category includes Vita Coco product extensions beyond coconut water, such as coconut milk products, including Vita Coco Treats; PWR LIFT ; Ever & Ever ; Runa (until the Company ceased selling in December 2023); Vita Coco coconut oil sold internationally; and other revenue transactions (e.g., bulk product sales). For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. 72 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) The Company excludes from revenues all taxes assessed by a governmental authority that are imposed on the sale of its products and collected from customers. Disaggregation of Revenue The following table disaggregates net revenue by product type and reportable segment: December 31, 2025 Americas International Consolidated Vita Coco Coconut Water $ 424,319 $ 71,943 $ 496,262 Private Label 62,731 25,951 88,682 Other 21,723 3,113 24,836 Total $ 508,773 $ 101,007 $ 609,780 December 31, 2024 Americas International Consolidated Vita Coco Coconut Water $ 343,288 $ 50,318 $ 393,606 Private Label 89,900 19,324 109,224 Other 9,155 4,028 13,183 Total $ 442,343 $ 73,670 $ 516,013 December 31, 2023 Americas International Consolidated Vita Coco Coconut Water $ 317,221 $ 41,829 $ 359,050 Private Label 103,166 18,713 121,879 Other 9,858 2,825 12,683 Total $ 430,245 $ 63,367 $ 493,612 4. ACCOUNTS RECEIVABLE, NET Accounts receivable, net was $ 81,514 and $ 63,450 as of December 31, 2025 and 2024, respectively. The Company recorded an allowance for current expected credit losses of $ 2,660 and $ 2,255 as of December 31, 2025 and 2024, respectively. Changes in the allowance for current expected credit losses for the periods presented were as follows: Balance at January 1, 2024 $ 2,486 Current period provision for expected credit losses 2,966 Account write-offs and other deductions, net of recoveries ( 3,197 ) Balance as of December 31, 2024 $ 2,255 Current period provision for expected credit losses 4,662 Account write-offs and other deductions, net of recoveries ( 4,257 ) Balance as of December 31, 2025 $ 2,660 5. INVENTORY Inventory consists of the following: 73 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) December 31, 2025 2024 Raw materials and packaging $ 5,353 $ 3,536 Finished goods 106,115 80,064 Inventory $ 111,468 $ 83,600 6. PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets consist of the following: December 31, 2025 2024 State and Federal Tax receivables $ 7,198 $ 5,737 VAT receivables 7,005 1,790 Supplier prepaid 3,473 4,767 Contract assets 3,131 4,804 Lease Incentive Receivables 1,690 — Supplier Incentives Receivables 1,442 1,590 Restricted Cash 1,281 1,264 Prepaid IT Subscriptions 1,230 566 Prepaid insurance 678 1,230 Interest Receivable 525 462 GST/HST Receivable 353 893 Other prepaid expenses 1,557 2,077 Other receivables 597 2,056 $ 30,160 $ 27,236 7. PROPERTY AND EQUIPMENT, NET Property and equipment, net consist of the following: December 31, 2025 2024 Leasehold improvements $ 6,290 $ 393 Computer software and hardware 4,654 3,895 Machinery and equipment 2,682 2,271 Furniture and fixtures 1,575 708 Vehicles 624 624 Land and improvements — 140 Total Property and equipment 15,825 8,031 Less accumulated depreciation and amortization ( 6,527 ) ( 5,680 ) Property and equipment—net $ 9,298 $ 2,351 Depreciation expense related to property and equipment, net for the years ended December 31, 2025, 2024, and 2023 was $ 1,072 , $ 745 and $ 660 , respectively. 74 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) In the year ended December 31, 2023, the Company reclassified its long-lived assets in Ecuador related to its Runa product and related production assets from held for sale to held and used within property and equipment and recorded an impairment charge to reduce the carrying amount of the asset group to its estimated fair value of $ 140 . In 2025, the Company recorded an impairment loss of $ 140 related to this land and impaired the remaining assets related to Runa , which is included in selling, general and administrative expenses in the Consolidated Statements of Operations for the year ended December 31, 2025. 8. GOODWILL AND INTANGIBLE ASSETS Goodwill consists of the following: December 31, 2025 2024 Goodwill $ 7,791 $ 7,791 Annual Goodwill Impairment Testing The Company’s goodwill is allocated to the Americas reporting unit and is tax deductible. As of December 31, 2025, the Company performed the qualitative assessment only, which did not indicate that it is more likely than not that the carrying value of each of the reporting units exceeds their fair value, resulting in no further quantitative testing. Based on the results of the annual impairment test, the Company concluded that no impairment to goodwill existed as of December 31, 2025, 2024, and 2023. Intangible Assets, ne t Long-lived intangible assets are amortized over their useful life. Since the intangibles are subject to amortization, they are reviewed for impairment in accordance with ASC 360, Property, Plant, and Equipment. Under ASC 360, long-lived assets are tested for recoverability at the asset group level whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. In step 1, the entity determines recoverability of the asset group by comparing its carrying value with the sum of its undiscounted cash flows expected to result from the use and eventual disposition of the asset group. If the sum of the undiscounted cash flows is less than the carrying value of the asset group, then step 2 must be performed, in which the entity compares the fair value of the asset group to its carrying amount. The excess of the carrying value of the asset group over its fair value, if any, would be recognized as an impairment loss. Intangible assets, net was $ 0 as of December 31, 2025 and December 31, 2024. Amortization expense for the years ended December 31, 2025, December 31, 2024 and December 31, 2023 was $ 0 , $ 0 and $ 0 , respectively, and was recorded in selling, general and administrative expenses on the Company's consolidated statements of operations. 9. ACCRUED EXPENSES Accrued expenses consist of the following: 75 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) December 31, 2025 2024 Accrued promotions and marketing $ 22,048 $ 22,380 Income Tax payable 21,093 10,559 Payroll and benefits related expenses 15,841 10,388 Shipping and handling costs 12,102 11,932 Accrued trade payable 6,361 1,242 VAT Payable 3,642 2,652 Operating Lease Liabilities - ST 1,727 422 Accrued Professional fees 1,200 1,269 Other accrued expenses 5,444 4,759 $ 89,458 $ 65,603 10. DEBT The table below details the outstanding balances on the Company’s credit facility and notes payable as of December 31, 2025 and 2024: December 31, 2025 2024 Notes payable Vehicle loans 3 13 $ 3 $ 13 Current $ 3 $ 10 Non-current $ — $ 3 Credit Facility In May 2020, the Company entered into a five-year credit facility (the "Credit Facility") with Wells Fargo Bank, National Association consisting of a revolving line of credit, which currently provides for committed borrowings of $ 60,000 . On February 14, 2025, the Credit Facility was amended, extending the maturity date five years to February 13, 2030. In connection with the amendment, the Company capitalized $ 90 of deferred financing costs, which are being amortized over the term of the facility. As of December 31, 2025, the unamortized deferred financing fees related to the revolver totaled $ 74 and are included in Other assets on the Company’s consolidated balance sheet. Borrowings on the Credit Facility bear interest at rates based on either: 1) a fluctuating rate per annum determined to be the sum of Daily Simple Secured Overnight Financing Rate ("SOFR") plus a spread defined in the credit agreement (the "Spread"); or 2) a fixed rate per annum determined to be the sum of the Term SOFR plus the Spread. The Spread ranges from 1.00 % to 1.75 %, which is based on the Company’s leverage ratio (as defined in the credit agreement) for the immediately preceding fiscal quarter as defined in the credit agreement. In addition, the Company was subject to unused commitment fees ranging from 0.10 % and 0.20 % on the unused amount of the line of credit through February 13, 2025, with the rate based on the Company’s leverage ratio (as defined in the Credit Facility). Starting February 14, 2025, the unused commitment fees range from 0.13 % and 0.23 % on the unused amount of the line of credit, with the rate being based on the Company’s leverage ratio (as defined in the Credit Facility). As of December 31, 2025 and December 31, 2024, the Company had no outstanding balance and $ 60,000 undrawn and available under its amended Credit Facility. The Company incurred no interest expense for the Credit Facility for the year ended December 31, 2025 and 2024, respectively. The unused commitment fee for the Credit Facility amounted to $ 73 and $ 61 for the year ended December 31, 2025 and 2024, respectively. Interest expense and unused 76 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) commitment fee for the Credit Facility amounted to $ 14 and $ 46 , respectively, for the year ended December 31, 2023. The effective interest rate was 0.13 %, 0.10 %, and 0.10 %, respectively, as of December 31, 2025, 2024, and 2023. The Credit Facility is collateralized by substantially all of the Company’s assets. The Credit Facility contains certain affirmative and negative covenants that, among other things, limit the Company’s ability to, subject to various exceptions and qualifications: (i) incur liens; (ii) incur additional debt; (iii) sell, transfer or dispose of assets; (iv) merge with or acquire other companies, (v) make loans, advances or guarantees; (vi) make investments; (vii) make dividends and distributions on, or repurchases of, equity; and (viii) enter into certain transactions with affiliates. The Credit Facility also requires the Company to maintain certain financial covenants including a maximum leverage ratio, a minimum fixed charge coverage ratio, and a minimum asset coverage ratio. As of December 31, 2025, the Company was compliant with all financial covenants. 11. COMMITMENTS AND CONTINGENCIES Contingencies: Litigation —The Company may engage in various litigation in the ordinary course of business. The Company intends to vigorously defend itself in such matters and management, based upon the advice of legal counsel, is of the opinion that the resolution of these matters will not have a material effect on the consolidated financial statements. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. The Company also discloses when it is reasonably possible that a material loss may be incurred. As of December 31, 2025 and 2024, the Company did not record liabilities relating to such legal matters. Business Risk —The Company imports finished goods predominantly from manufacturers located in South American and Asian countries. The Company may be subject to certain business risks due to potential instability in these regions. Major Customers — The Company’s customers that accounted for 10% or more of total net sales and total accounts receivable attributable to the Americas reportable segment were as follows: Net sales Accounts receivable Year Ended December 31, December 31, 2025 2024 2023 2025 2024 Customer A 19 % 25 % 30 % 9 % 13 % Customer B 25 % 23 % 23 % 30 % 17 % One of the customers acquired less than 5% ownership in the Company upon consummation of the IPO. The same customer also was granted 200,000 restricted stock awards at the time of the IPO, of which 100,000 vested on March 31, 2023 and 100,000 vested on March 31, 2024. The customer monetized its investment in the Company during the first quarter of 2025. In 2023, the Company agreed to start to discontinue the Private Label coconut water and coconut oil supply relationship with one of the significant customers as the terms required to retain the business were contrary to the long term margin targets. However, at the request of this customer, the supply relationship continued for a significant portion of their Private Label coconut water needs in 2024. During 2025, the Company experienced a decrease in the number of regions that the Company services for Private Label for this customer. Major Suppliers — The Company’s suppliers that accounted for 10% or more of the Company’s purchases were as follows: 77 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Year Ended December 31, 2025 2024 Supplier A 18 % 18 % Supplier B 13 % 15 % Supplier C 10 % 8 % 12. DERIVATIVE INSTRUMENTS The Company accounts for derivative instruments in accordance with the ASC Topic 815, Derivatives and Hedging ("ASC 815"). These principles require that all derivative instruments be recognized at fair value on each balance sheet date unless they qualify for a scope exclusion as a normal purchase or sale transaction, which is accounted for under the accrual method of accounting. In addition, these principles permit derivative instruments that qualify for hedge accounting to reflect the changes in the fair value of the derivative instruments through earnings or stockholders’ equity as other comprehensive income on a net basis until the hedged item is settled and recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative instrument’s change in fair value is immediately recognized in earnings. As of December 31, 2025 and December 31, 2024, the Company did not have any derivative instruments that it had designated as fair value or cash flow hedges, and therefore all changes in fair value were immediately recognized in earnings. The Company is subject to the following currency risks: Inventory purchases from Brazilian, Thai and Malaysian manufacturers— In order to mitigate the currency risk on inventory purchases from its Brazilian, Malaysian and Thai manufacturers, which are settled in Brazilian real ("BRL"), Malaysian ringgit ("MYR") and Thai baht ("THB"), the Company's subsidiary, All Market Singapore Pte. Ltd. ("AMS"), enters a series of forward currency swaps to buy BRL, MYR and THB. Intercompany transactions between AME and AMS— In order to mitigate the currency risk on intercompany transactions between AME and AMS, AMS enters into foreign currency swaps to sell British pound ("GBP"). Intercompany Transactions with Canadian Customer and Vendors— In order to mitigate the currency risk on transactions with Canadian customer and vendors, the Company enters into foreign currency swaps to sell Canadian dollars ("CAD"). The notional amount and fair value of all outstanding derivative instruments in the consolidated balance sheets consist of the following at: 78 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) December 31, 2025 Derivatives not designated as hedging instruments under ASC 815-20 Notional Amount Fair Value Balance Sheet Location Assets Foreign currency exchange contracts Receive BRL/sell USD $ 21,769 $ 543 Derivative assets Receive THB/sell USD 23,620 189 Derivative assets Liabilities Foreign currency exchange contracts Receive USD/pay GBP $ 39,878 $ ( 854 ) Derivative liabilities Receive USD/pay EUR 27,531 ( 324 ) Derivative liabilities Receive USD/pay CAD 16,043 ( 329 ) Derivative liabilities December 31, 2024 Derivatives not designated as hedging instruments under ASC 815-20 Notional Amount Fair Value Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay EUR $ 9,060 $ 458 Derivative assets Receive USD/pay GBP 26,303 464 Derivative assets Receive USD/pay CAD 8,486 460 Derivative assets Liabilities Foreign currency exchange contracts Receive THB/sell USD $ 28,066 $ ( 623 ) Derivative liabilities Receive BRL/sell USD 35,443 ( 6,272 ) Derivative liabilities The amount of realized and unrealized gains and losses and consolidated statements of operations and comprehensive income location of the derivative instruments as of December 31, 2025 and 2024 are as follows: 2025 2024 2023 Unrealized gain (loss) on derivative instruments $ 4,737 $ ( 8,176 ) $ ( 872 ) Foreign currency gain (loss) $ ( 3,314 ) $ ( 1,067 ) $ 5,697 The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC Topic 820, Fair Value Measurements ("ASC 820"). In determining fair value, the Company used a market approach and incorporates the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable internally developed inputs. 13. FAIR VALUE MEASUREMENTS ASC 820 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. 79 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Based upon observability of the inputs used in valuation techniques, the Company’s assets and liabilities are classified as follows: • Level 1— Quoted market prices in active markets for identical assets or liabilities. • Level 2— Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted market prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. • Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes internally developed models and methodologies utilizing significant unobservable inputs. Forward currency swap contracts— See Note 12, Derivative Instruments, for a description of these contracts. The Company’s valuation methodology for forward currency swap contracts is based upon third-party institution data. The Company’s fair value hierarchy for those assets (liabilities) measured at fair value on a recurring basis at December 31, 2025 and 2024, is as follows: Level 1 Level 2 Forward Currency Swaps/Contracts Level 3 Contingent consideration liability Total December 31, 2025 $ — $ ( 775 ) $ — $ ( 775 ) December 31, 2024 $ — $ ( 5,513 ) $ — $ ( 5,513 ) There were no transfers between any levels of the fair value hierarchy for any of the Company’s fair value measurements. 14. STOCKHOLDERS’ EQUITY Common Stock — Each share of common stock entitles its holder to one vote on matters required to be voted on by the stockholders of the Company and to receive dividends, when and if declared by the Company’s board of directors (the "Board"). In May 2023, 5,000,000 of the Company’s common stock were sold by Verlinvest Beverages SA (the “Selling Stockholder”) at $ 23.00 per share (the “Closing”) pursuant to an underwriting agreement (the “May Underwriting Agreement”). Additionally, under the May Underwriting Agreement, the Selling Stockholder granted the underwriters an option exercisable to purchase up to an additional 750,000 shares from the Selling Shareholder at the public offering price which was exercised in full prior to the Closing. In November 2023, the Selling Stockholder sold an additional 4,000,000 shares of the Company’s common stock at $ 27.61 per share pursuant to an underwriting agreement (the “November Underwriting Agreement”). The Company did not receive proceeds from the sale of the shares under the May Underwriting Agreement or the November Underwriting Agreement. For the year ended December 31, 2023, the Company recorded $ 1,525 of administrative expenses related to the May and November Underwriting Agreements, net of legal fee waiver of $ 140 related to May 2023 secondary offering. These administrative expenses are included in Selling, general, and administrative expenses ("SG&A") in the consolidated statement of operations. Additionally, the Selling Stockholder provided additional waiver of legal fees of $ 324 related to November 2023 secondary offering for the year ended December 31, 2024. Treasury Stock - As of December 31, 2025 and 2024, the Company held 7,104,376 and 6,740,446 shares in treasury stock. In January 2021, the Company entered into a Stock Purchase Agreement with RW VC S.a.r.l, f/k/a Vita Coco S.a.r.l (the “Seller”). The Company repurchased 5,192,005 shares of its own common stock from the Seller at a purchase price of $ 9.63 per share, or an aggregate purchase price of approximately $ 50,000 . The purchase price per share approximated the most recent third-party common stock valuation prepared in conjunction with the accounting of stock-based compensation discussed within Note 15. 80 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) On October 30, 2023, the Board approved a share repurchase program ("Program") authorizing the Company to repurchase up to $ 40,000 of the Company's common stock. On April 28, 2025, the Company's Board approved an additional $ 25,000 to the Repurchase Program, authorizing the Company to repurchase up to a total of $ 65,000 of the Company's Common Stock. There were no other changes made to the terms of the Repurchase Program. Shares of the Company's common stock may be repurchased under the Program from time to time through open market purchases, block trades, private transactions or accelerated or other structured share repurchase programs. To the extent not retired, shares of the Company's common stock repurchased under the Program will be placed in the Company's treasury shares. The extent to which the Company repurchases shares of the Company's common stock, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by the Company. The Program has no time limits and may be suspended or discontinued at any time. The Company repurchased 363,930 shares under this program at a cost of $ 11,269 during the year ended December 31, 2025. The Company repurchased 504,246 shares under this program at a cost of $ 12,030 during the year ended December 31, 2024. As of December 31, 2025, $ 40,928 remained available for future purchases under the Program. 15. STOCK-BASED COMPENSATION The stockholders of the Company approved the adoption of the Company’s 2014 Stock Option and Restricted Stock Plan (the “2014 Plan”). The 2014 Plan allowed for a maximum of 8 % of the sum of the Available Equity defined as the sum of (i) the total then outstanding shares of common shares and (ii) all available stock option (i.e., granted and outstanding stock options and stock options not yet granted). Under the terms of the 2014 Plan, the Company may grant employees, directors, and consultants stock options and restricted stock awards and has the authority to establish the specific terms of each award, including exercise price, expiration, and vesting. Currently, only stock options were granted under the 2014 Plan. Generally, stock options issued pursuant to the 2014 Plan must contain exercise prices no less than the fair value of the Company’s common stock on the date of grant and have a ten-year contractual term. Subsequent to September 30, 2021, the stockholders of the Company approved the adoption of the 2021 Incentive Award Plan ("2021 Plan"), which became effective after the closing of the IPO. On and after closing of the offering and the effectiveness of the 2021 Incentive Award Plan, no further grants will be made under the 2014 Plan. The maximum number of shares of the Company's common stock available for issuance under the 2021 Plan is equal to the sum of (i) 3,431,312 shares of the Company's common stock and (ii) an annual increase on the first day of each year beginning in 2022 and ending in and including 2031, equal to the lesser of (A) two percent ( 2 %) of the outstanding shares of the Company's common stock on the last day of the immediately preceding fiscal year and (B) such lesser amount as determined by the Board; provided, however, no more than 3,431,312 shares may be issued upon the exercise of incentive stock options, or ISOs. The 2021 Plan provides for the grant of stock options, including ISOs and nonqualified stock options, or NSOs, restricted stock, dividend equivalents, stock payments, RSUs, other incentive awards, stock appreciation rights, and cash awards. Stock options, restricted stock, and RSU's were granted under 2021 Plan. As of December 31, 2025, there were 2,941,343 shares of the Company's common stock reserved for future issuance pursuant to the 2021 Plan. For the year ended December 31, 2025, 2024, and 2023 the Company recorded stock compensation costs totaling: Year Ended December 31, 2025 2024 2023 Reduction in revenue (1) $ — $ 151 $ 1,323 Selling, general & administrative expenses $ 10,843 $ 8,771 $ 7,805 Total stock compensation expense $ 10,843 $ 8,922 $ 9,128 (1) The cost recognized as a reduction in revenue is related to the RSUs previously granted to a major customer based on guidance in ASC 606 as a stock-based sales incentive. These awards are shares of restricted Common Stock valued at $ 3,000 granted at the time of the IPO to an entity affiliated with a significant customer, at $ 15.00 per share, or 200,000 restricted shares, in connection with an amendment to extend the distributor agreement term to June 10, 2026. Since the distribution agreement had not been terminated by either party for cause as of March 31, 2023, 50 % of the shares were released on March 31, 2023. The remaining 50 % were released on March 31, 2024. Stock Option Awards with Service-based Vesting Conditions 81 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Most stock option awards granted under the 2014 and 2021 Plans vest based on the continuous service. The stock options awarded to the employees have different vesting schedules as specified in each grant agreement. The following table summarizes the service-based stock option activity during the year ended December 31, 2025: Number of Stock Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value (per option) (in years) (in thousands) Outstanding—December 31, 2024 3,054,060 $ 13.14 Granted 201,100 $ 32.95 Exercised 356,321 $ 10.46 Forfeited or expired 25,443 $ 15.35 Outstanding—December 31, 2025 2,873,396 $ 14.78 5.5 $ 111,319 Exercisable—December 31, 2025 2,378,997 $ 12.51 5.0 $ 96,360 The weighted average grant-date fair value of the service-based stock option awards granted during the years ended December 31, 2025 and 2024 was $ 13.08 per option and $ 10.52 per option, respectively. The aggregate intrinsic value of service-based stock options exercised was $ 15,161 and $ 8,921 for the years ended December 31, 2025 and 2024, respectively. The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for all stock options that had exercise prices lower than the fair value of the Company’s common stock. The fair value of the service-based stock options granted in 2025 and 2024 pursuant to the Stock Option Plan was estimated on a grant or on a modification date using the Black-Scholes option-pricing model. The weighted average assumptions used in the Black-Scholes option-pricing model were as follows: 2025 2024 Weighted average expected term 6.25 years 6.25 years Weighted average expected volatility 31 % 32 % Weighted average risk-free interest rate 4.10 % 4.00 % Weighted average expected dividend yield 0 % 0 % Expected Term: Represents the period that the stock-based awards are expected to be outstanding based on a contractual term and service conditions specified for the awards. The Company estimated the expected term of the options with service conditions in accordance with the “simplified” method as defined in ASC 718, which enables the use of a practical expedient for “plain vanilla” share options. Expected Volatility : The Company has historically been a private company and lacks company-specific historical and implied volatility information for its stock. Therefore, the Company estimated volatility for option grants by evaluating the average historical volatility of a peer group of companies for the period immediately preceding the option grant for a term that is approximately equal to the expected term of the options. Risk-free Interest Rate: The risk-free interest rate was based on the yield, as of the option valuation date, by reference to the U.S. Treasury yield curve in effect at the time of the grant or the modification of the award for time periods equal to the expected term of the award. Dividend Yield —The Company does not anticipate declaring a dividend over the expected term. As such, the dividend yield has been estimated to be zero . Fair Value of Common Stock — For stock awards granted subsequent to the IPO, the fair value of the Company's common stock assumed for the grant date fair value of the awards will be based on the closing price of the Company's 82 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) common stock as reported on the day of grant. Prior to the IPO in October 2021, because there has been no public market for the Company’s common stock, the Board has determined the estimated fair value of the Company's common stock at the time of grant of options by considering valuations performed by an independent third-party valuation specialist, which considers a number of objective and subjective factors including valuations of comparable companies, operating and financial performance, the lack of liquidity of capital stock, the likelihood of achieving an initial public offering and general and industry specific economic outlook. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants’ Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation . The third-party common stock valuations were prepared using a combination of the income approach and market approach. As of December 31, 2025, there was $ 2,233 of total unrecognized compensation cost related to unvested service-based stock options, which is expected to be recognized over a weighted-average service period of 1.9 years. Stock Option Awards with Performance and Market-based Vesting Conditions There are also stock option awards containing performance-based vesting conditions, subject to achievement of various performance goals by a future period, such as revenue and Adjusted EBITDA targets. There are also stock option awards containing performance and market vesting conditions, such as options vesting upon occurrence of an IPO or other qualifying liquidity event and upon achieving a predetermined equity value of the Company. This award was granted to the current CEO in 2019 that vest upon occurrence of an IPO or other qualifying liquidity event and upon achieving a predetermined equity value of the Company. As of July 31, 2023, the performance and market vesting conditions were achieved and the remaining stock compensation expense of $ 762 for this award was accelerated and recognized in the year ended December 31, 2023. During the years ended December 31, 2025 and December 31, 2024, there were no modifications to these awards. The following table summarizes the stock option activity during the year ended December 31, 2025: Number of Stock Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term Aggregate Intrinsic Value (per option) (in years) (in thousands) Outstanding—December 31, 2024 1,144,436 $ 12.60 Granted — — Exercised — — Forfeited or expired — — Outstanding—December 31, 2025 1,144,436 $ 12.60 5.1 $ 46,243 Exercisable—December 31, 2025 709,346 $ 10.18 3.9 $ 30,383 . The fair value of the awards with performance-based vesting conditions was estimated using the Black-Scholes option-pricing model used for the Company’s service-based stock options and assumed that performance goals will be achieved. If such performance conditions are not met, no compensation cost is recognized and any recognized compensation cost is reversed. The Company did not grant any performance based options for the year ended December 31, 2025. As of December 31, 2025, total unrecognized compensation cost related to the unvested stock option awards containing performance conditions was $ 185 , which is expected to be recognized over the period of approximately 0.2 years. 83 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Service & Performance Based Restricted Stock Awards ("RSUs") RSUs were granted under the 2021 Plan and primarily vest based on continuous service. The RSUs with service-based vesting conditions awarded to employees have differing vesting schedules as specified in each grant agreement. The RSUs granted to non-employee directors vest in full on the earlier of: (i) the day immediately preceding the date of the first Annual Shareholders Meeting following the date of grant; or (ii) the first anniversary of the date of grant. During the twelve months ended December 31, 2025, the Company also granted RSUs that contained performance-based vesting conditions, subject to achievement of various performance goals by the end of 2025 or 2026, specifically net sales growth and Adjusted EBITDA targets. The following table summarizes the restricted stock and RSU activity for the year ended December 31, 2025: Number of service based Restricted Stock or RSU Awards Weighted Average Grant Date Fair Value (service based) Number of performance based Restricted Stock or RSU Awards Weighted Average Grant Date Fair Value (performance based) Non-vested - December 31, 2024 634,803 $ 19.99 74,579 $ 23.97 Granted 214,468 33.66 71,140 32.89 Vested 216,411 19.17 — — Forfeited/Cancelled 24,657 23.69 1,528 26.18 Non-vested - December 31, 2025 608,203 $ 24.95 144,191 $ 28.35 The aggregate grant date fair value of service and performance based RSUs granted during 2025 and 2024 was $ 7,219 and $ 8,609 , respectively. At December 31, 2025, there was $ 6,217 of unrecognized stock compensation expense related to non-vested service-based RSUs, which is expected to be recognized over a weighted average period of 1.8 years and $ 1,954 of unrecognized stock compensation expense related to non-vested performance based RSUs, which is expected to be recognized over a weighted average period of 1.2 years. 84 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) 16. INCOME TAXES The domestic and foreign components of the Company’s income before income taxes are as follows: Year Ended December 31, 2025 2024 2023 Domestic $ 51,898 $ 42,131 $ 31,614 Foreign 41,073 28,657 26,306 Income before income taxes $ 92,971 $ 70,788 $ 57,920 The income tax expense for the years ended December 31, 2025, 2024, and 2023 consist of the following: Year Ended December 31, 2025 2024 2023 Current Federal $ 10,057 $ 6,055 $ 6,926 State and local 3,927 3,050 1,911 Foreign 8,031 5,088 4,940 22,015 14,193 13,777 Deferred Federal $ ( 233 ) $ 166 $ ( 2,044 ) State and local ( 214 ) 192 ( 629 ) Foreign 83 285 187 ( 364 ) 643 ( 2,486 ) Total $ 21,651 $ 14,836 $ 11,291 The reconciliation of the U.S. federal statutory rate to the Company’s effective rate is as follows: 2025 2024 2023 Amount Percentage Amount Percentage Amount Percentage U.S. Federal Statutory Rate $ 19,524 21.0 % $ 14,865 21.0 % $ 12,163 21.0 % State and Local Income Taxes, Net of Federal Income Tax Effect 2,945 3.2 % 2,723 3.8 % 1,048 1.8 % Foreign Tax Effects Singapore Statutory tax rate difference between Singapore and United States ( 1,210 ) ( 1.3 %) ( 943 ) ( 1.3 %) ( 840 ) ( 1.5 %) Other 331 0.4 % ( 104 ) ( 0.1 %) 443 0.8 % Other foreign jurisdictions 366 0.4 % 401 0.6 % — — % Effect of Cross-Border Tax Laws — % Global intangible low-taxed income 4,804 5.2 % 3,615 5.1 % 2,953 5.1 % Foreign-derived intangible income ( 730 ) ( 0.8 %) ( 727 ) ( 1.0 %) ( 188 ) ( 0.3 %) Tax Credits Federal foreign tax credit ( 4,804 ) ( 5.2 %) ( 3,927 ) ( 5.5 %) ( 2,951 ) ( 5.1 %) Nontaxable or Nondeductible Items Stock option exercise windfall ( 2,892 ) ( 3.1 %) ( 1,383 ) ( 2.0 %) ( 1,932 ) ( 3.3 %) 162(m) limitation 2,445 2.6 % 872 1.2 % 660 1.1 % Other nontaxable or nondeductible items 97 0.1 % 105 0.1 % 104 0.2 % Other Adjustments 775 0.8 % ( 661 ) ( 0.9 %) ( 169 ) ( 0.3 %) Effective Tax Rate $ 21,651 23.3 % $ 14,836 21.0 % $ 11,291 19.5 % 1 State taxes in CA, NY, NJ and IL made up the majority (greater than 50 percent) of the tax effect in this category 85 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Deferred tax assets and liabilities at December 31, 2025 and 2024, consist of the following: 2025 2024 Deferred Tax Assets Inventory reserves $ 472 $ 601 Reserves and accruals 1,556 1,150 Stock based compensation 7,046 6,268 Net operating loss carryforwards 3,639 3,577 Lease liability 3,129 291 Subtotal 15,842 11,887 Valuation allowance ( 3,651 ) ( 3,587 ) Total deferred tax assets 12,191 8,300 Deferred Tax Liabilities Prepaid insurance ( 61 ) ( 273 ) Intangibles ( 1,562 ) ( 1,509 ) Right-of-use assets ( 2,352 ) ( 252 ) Fixed assets ( 1,764 ) ( 329 ) Other, net 11 163 Total deferred tax liabilities ( 5,728 ) ( 2,200 ) Net deferred tax assets (liability) $ 6,463 $ 6,100 A valuation allowance of $ 3,651 and $ 3,587 was recorded against the non-U.S. deferred tax asset balance as of December 31, 2025 and 2024, respectively. As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. As of December 31, 2025 and 2024, management determined that there is sufficient positive evidence to conclude that it is more likely than not that the U.S. deferred taxes are realizable. A valuation allowance has been established against the net operating loss carryforwards which have been generated by the Company's foreign jurisdictions. As of December 31, 2025 and 2024, the Company had no U.S. state and federal net operating loss carryforwards. As of December 31, 2025 and 2024, the Company had net operating loss carryforwards related to foreign operations of $ 17,572 and $ 18,309 , respectively. These net operating loss carryforwards have various lives remaining ranging from 10 years to indefinite carryforward periods. A reconciliation of the beginning and ending amount of income tax uncertainties is as follows: 2025 Beginning balance as of January 1, 2025 $ 106 Reductions based on tax positions related to prior years ( 17 ) Additions based on tax positions related to current year — Ending balance as of December 31, 2025 $ 89 As of December 31, 2025 and 2024, there were $ 89 and $ 106 liabilities for income tax uncertainties recorded in the Company’s consolidated balance sheets. The Company recognized interest and penalties related to income tax uncertainties of $ 31 and $ 37 in its consolidated statements of operations for years ended December 31, 2025 and 2024, respectively. The Company is subject to income tax examinations by the IRS and various state and local jurisdictions for the open tax years between December 31, 2022 and December 31, 2025. 86 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Cash paid for income taxes (net of refunds) is as follows: Year Ended December 31, 2025 2024 2023 Federal $ 5,048 $ 5,337 $ 6,200 State and local 2,433 2,571 2,326 Foreign 5,639 5,073 1,379 Total income taxes paid (net of refunds) $ 13,120 $ 12,981 $ 9,905 Income Taxes Paid (net of refunds) exceeded 5 percent of total income taxes paid (net of refunds) in the following jurisdictions: State California * * $ 689 New Jersey * * $ 477 Foreign Singapore $ 4,010 $ 3,679 $ 1,378 United Kingdom $ 1,214 $ 1,395 * *Jurisdiction below the threshold for period presented. As of December 31, 2025 and 2024, income taxes on undistributed earnings of the Company’s foreign subsidiaries have not been provided for as the Company plans to indefinitely reinvest these amounts. The cumulative undistributed foreign earnings were not material as of December 31, 2025 and 2024. On July 4, 2025, the United States enacted tax reform legislation through the passage of H.R.1, One Big Beautiful Bill Act, which changes existing U.S. tax laws, including extending or making permanent certain provisions of the 2017 Tax Cuts and Jobs Act, and repealing certain clean energy initiatives, in addition to other changes. The impact of these changes was not material as of December 31, 2025 . 87 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) 17. EARNINGS PER SHARE Basic and diluted earnings per share is calculated as follows: Year Ended December 31, 2025 2024 2023 Numerator: Net income attributable to The Vita Coco Company, Inc. $ 71,320 $ 55,952 $ 46,629 Denominator: Weighted-average number of common shares used in earnings per share—basic 56,913,810 56,729,370 56,427,890 Effect of conversion of stock options and RSU's 3,053,881 2,557,192 2,319,448 Weighted-average number of common shares used in earnings per share—diluted 59,967,691 59,286,562 58,747,338 Earnings per share—basic $ 1.25 $ 0.99 $ 0.83 Earnings per share—diluted $ 1.19 $ 0.94 $ 0.79 The following potentially dilutive securities have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: Year Ended December 31, 2025 2024 2023 Stock options and restricted stock awards 188,440 210,933 310,953 18. EMPLOYEE BENEFIT PLAN Employees of the Company may participate in a defined contribution plan which qualifies under Section 401(k) of the Internal Revenue Code. Participating employees may contribute into a traditional plan with pretax salary or into a Roth plan with after tax salary up to statutory limits. The Company matches contributions up to 3 % of each employee’s earnings, which vest over two years . Matching contributions were $ 1,082 , $ 845 and $ 616 for the years ended December 31, 2025, 2024, and 2023, respectively. 19. SEGMENT REPORTING The Company has two operating and reportable segments: • Americas—The Americas segment is comprised primarily of the U.S. and Canada and derives its revenues from the marketing and distribution of various coconut water and non-coconut water products (e.g., coconut oil and milk). The Company’s sustainably packaged water ( Ever & Ever ) and protein infused fitness drink ( PWR LIFT ), guayusa leaf products ( Runa ), are or were, in the case of Runa , marketed only in the Americas segment. As of December 2023, the Company ceased offering the Runa brand. • International—The International segment is comprised primarily of Europe, Middle East, and Asia Pacific, which includes the Company’s procurement arm and derives its revenues from the marketing and distribution of various coconut water and non-coconut water products, which in some cases may be shipped directly to customers outside of Asia Pacific regions. The Company’s Chief Executive Officer is the chief operating decision maker ("CODM") and manages and allocates resources between the Americas and International segments. Consistent with this decision-making process, the CODM uses financial information disaggregated between the Americas and International segment for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. The CODM evaluates segment business performance based primarily on net sales and gross profit. The CODM considers 88 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) budget-to-actual variances on a monthly basis for both profit measures when making decisions about allocating capital and personnel to the segments and also uses segment gross profit for evaluating product pricing. All intercompany transactions between the segments have been eliminated. Information about the Company’s operations by operating segment as of and for the years ended December 31, 2025, 2024, and 2023 is as follows: December 31, 2025 Americas International Consolidated Net sales $ 508,773 $ 101,007 $ 609,780 Cost of goods sold 321,464 65,721 387,185 Gross profit 187,309 35,286 222,595 Total segment assets 302,185 158,973 461,158 December 31, 2024 Americas International Consolidated Net sales $ 442,343 $ 73,670 $ 516,013 Cost of goods sold 268,787 48,443 317,230 Gross profit 173,556 25,227 198,783 Total segment assets 241,894 120,487 362,381 December 31, 2023 Americas International Consolidated Net sales $ 430,245 $ 63,367 $ 493,612 Cost of goods sold 267,983 44,900 312,883 Gross profit 162,262 18,467 180,729 Total segment assets 209,984 75,698 285,682 Year Ended December 31, Reconciliation 2025 2024 2023 Total gross profit $ 222,595 $ 198,783 $ 180,729 Less: Selling, general, and administrative expenses 140,063 124,963 124,236 Income from operations 82,532 73,820 56,493 Less: Unrealized gain/(loss) on derivative instruments 4,737 ( 8,176 ) ( 872 ) Foreign currency loss ( 1,037 ) ( 1,571 ) ( 251 ) Interest income, net 6,548 6,715 2,550 Other income $ 191 $ — $ — Income before income taxes $ 92,971 $ 70,788 $ 57,920 Geographic Data: The following table provides information related to the Company’s net revenues by country, which is presented on the basis of the location that revenue from customers is recorded: 89 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) Twelve Months Ended December 31, 2025 2024 2023 United States $ 471,497 $ 414,350 $ 401,974 United Kingdom 66,743 53,276 44,330 All other countries(1) 71,540 48,387 47,308 Net sales $ 609,780 $ 516,013 $ 493,612 (1) No individual country is greater than 10% of total net sales for the years ended December 31, 2025, 2024, and 2023. The following table provides information related to the Company’s property and equipment, net by country: December 31, 2025 December 31, 2024 United States $ 6,419 $ 758 Singapore 2,224 1,280 United Kingdom 655 173 All other countries(1) — 140 Property and equipment, net $ 9,298 $ 2,351 (1) No individual country is greater than 10% of total property and equipment, net as of December 31, 2025 and 2024 . 90 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) 20. RELATED-PARTY TRANSACTIONS Director Nominee Agreements - On May 24, 2022, a member of the Board appointed as a nominee under the Investor Rights Agreement by Verlinvest Beverages SA ("Verlinvest"), a stockholder of the Company, entered into a nominee agreement instructing the Company to pay all cash and equity compensation earned in connection with his board of director service to Verlinvest. Based on the aforementioned nominee agreement, until the termination of the agreement, RSUs granted to this director were held by him as a nominee for Verlinvest and, upon vesting of the RSUs, the shares were transferred to Verlinvest. The nominee agreement terminated on June 3, 2025 and is no longer in effect. Following termination of the agreement, the director receives all cash and equity compensation directly. The nominee agreement was primarily between the director and Verlinvest. The Company was a party to this arrangement solely to agree to the manner in which it would satisfy the compensation obligations to this director. As of December 31, 2025, there are no active members of the Board subject to this nominee agreement. Registration Rights and Underwriting Agreements - Under the Registration Rights agreement by and among the Company, Verlinvest Beverages SA ("Verlinvest") and certain other investors, in connection with each demand registration, piggyback or shelf offering, the Company agreed to reimburse the holders of registrable securities for the reasonable fees and disbursements of not more than one law firm. As part of the two secondary offerings during 2023, the Company also entered into underwriting agreements, to which Verlinvest was a party. In connection with the secondary share offerings by Verlinvest in May 2023 and November 2023, Verlinvest agreed to waive its right to reimbursement of legal fees for its counsel, and those expenses, in the amounts of $ 140 and $ 324 , respectively, were not reimbursed by the Company. Distribution Agreement with Stockholder – On October 1, 2019 the Company entered into a distribution agreement with one of its stockholders. The distribution agreement granted the stockholder the right to sell, resell and distribute designated products supplied by the Company within a specified territory. During the year ended December 31, 2023, the stockholder's ownership in the Company became less than 5%. Additionally, the distribution agreement with this stockholder ended during 2024. Revenue recognized related to this distribution agreement was $ 258 , $ 1,642 , and $ 4,048 for the years ended December 31, 2025, 2024, and 2023, respectively. The amounts due from the stockholder in Accounts Receivable, net were $ 0 , and $ 83 as of December 31, 2025, and 2024 respectively. There were $ 0 amounts payable to the stockholder in Accounts payable as of December 31, 2025 and 2024. Related to this distribution arrangement, the Company and the stockholder had a service agreement in which the Company shared in the compensation costs of the stockholder’s employee managing the China market. The Company recorded $ 10 , $ 181 , and $ 151 for the years ended December 31, 2025, 2024, and 2023, respectively, in selling, general, and administrative expenses for this service agreement . 91 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) 21. LEASES In January 2016, the Company entered into an operating lease for office space in New York, New York, which was set to expire in January 2023. The lease was extended to October 31, 2025 to allow for a smooth transition to the Company's new New York office. In August 2024, the Company signed a lease agreement for a new office in New York, New York. The operating lease commenced on January 1, 2025, and terminates in December 2034, with an option to extend for an additional two years . Total undiscounted future payments for this new office lease are $ 15,766 . The Company recognized ROU assets and lease liabilities of $ 10,002 and $ 11,692 , respectively, upon lease commencement on the Company’s consolidated balance sheet. Additionally, upon signing the agreement, the Company was required to establish a letter of credit of $ 920 which may be used in case of delinquency. As of December 31, 2025, the Company accounted for this letter of credit as restricted cash included in Prepaid and other current assets on the consolidated balance sheet. In November 2024, the Company signed a lease agreement for a new office in London, United Kingdom. The operating lease commenced on January 2, 2025 and terminates in December 2029. Total undiscounted future payments for this new office lease are $ 1,152 . The Company recognized ROU assets and lease liabilities of $ 1,140 and $ 1,252 respectively, upon lease commencement on the Company’s consolidated balance sheet . The Company agreed to establish a security deposit of $ 117 , which is refundable at the end of the lease period. In April 2025, the Company signed an agreement for a new office in Singapore. The operating lease commenced on April 1, 2025 and terminates in June 2030. Total undiscounted future payments for this new office lease are $ 1,675 . The Company recognized ROU assets and lease liabilities of $ 1,564 and $ 1,564 respectively, upon lease commencement on the Company’s consolidated balance sheet . As of December 31, 2025, the Company did not have any additional operating leases that have not yet commenced with future undiscounted lease payments. The components of lease cost, which are included within operating expenses in the accompanying consolidated statements of operations, are summarized in the following table (in thousands). Any variable lease costs are immaterial. Year Ended December 31, 2025 Year Ended December 31, 2024 Operating lease cost $ 2,801 $ 1,038 The following table summarizes supplemental balance sheet information for the Company’s operating leases: Line Item in Balance Sheet As of December 31, 2025 As of December 31, 2024 Noncurrent assets: Operating lease right-of-use assets Right-of-use assets, net $ 11,592 $ 385 Current liabilities: Current portion of operating lease liabilities Accrued expenses $ 1,727 $ 422 Noncurrent liabilities: Non-current portion of operating lease liabilities Other long-term Liabilities $ 13,087 $ — The following summarizes the weighted average remaining lease term and weighted average discount rate related to the Company’s right-of-use assets and lease liabilities recorded on the balance sheet as of December 31, 2025: 92 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) As of December 31, 2025 Weighted-average remaining lease terms 8.19 Weighted average discount rate 5.4 % The following table summarizes supplemental cash flow information for the Company’s operating leases: As of December 31, 2025 Cash paid for amounts included in the measurement of operating lease liabilities $ 1,492 The following table presents the maturity of the Company’s operating lease liabilities as of December 31, 2025: Year ending December 31, Maturity of Lease Payments 2026 $ 2,265 2027 2,289 2028 2,317 2029 2,344 2030 1,948 Thereafter 7,429 Total lease payments $ 18,592 Less: imputed interest 3,778 Total lease liabilities $ 14,814 93 Table of Contents THE VITA COCO COMPANY, INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2025, 2024 AND 2023 (Amounts in thousands, except for share and per share data) 22. INVESTMENT IN UNCONSOLIDATED JOINT VENTURE In accordance with ASC 323, Investments - Equity Method and Joint Ventures, investments in entities over which the Company does not have a controlling financial interest but has significant influence are accounted for using the equity method, with the Company’s share of earnings or losses reported in the consolidated statements of operations. Through one of its subsidiaries, the Company has a 60 % joint venture interest in a company, Coco Ventures Limited, which provides for the development, marketing, distribution and branding of coconut water-based products under the Vita Coco brand in China. Coco Ventures Limited purchases coconut water products from the Company. The Company acquired this interest on August 2, 2024, the date on which the Company obtained significant influence, for $ 585 to be paid in cash within one year. Per the joint venture agreement, the Company shall contribute its portion of capital funding per the operational funding requirement of the joint venture's business operations. The Company recorded the initial investment in the joint venture upon cash payment. Since the Company is deemed not to have a controlling interest in Coco Ventures Limited, the Company’s investment is accounted for using the equity method of accounting in accordance with ASC 323. As of December 31, 2025, the Company recognized an investment of $ 587 in Coco Ventures Limited. This amount includes $ 104 contributed during 2025 and $ 483 that was legally committed as of year‑end and subsequently funded on January 2, 2026. Coco Ventures Limited commenced operations in February 2025. The equity method investment is recorded in other assets on the consolidated balance sheet. Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. None